Back to Search
Start Over
Antileukemia T-cell responses in CLL – We don't need no aberration.
- Source :
- OncoImmunology; Jul2015, Vol. 4 Issue 7, pN.PAG-N.PAG, 0p
- Publication Year :
- 2015
-
Abstract
- Effective antigen-specific cancer immunotherapy requires exact knowledge of tumor-associated epitopes that can act as rejection antigens. Although the current paradigm views mutation-derived neoantigens as the most promising targets, we have recently demonstrated that leukemia-specific T-cell responses associated with survival benefit in CLL patients target a panel of non-mutated tumor-associated antigens. [ABSTRACT FROM PUBLISHER]
Details
- Language :
- English
- ISSN :
- 21624011
- Volume :
- 4
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- OncoImmunology
- Publication Type :
- Academic Journal
- Accession number :
- 103293308
- Full Text :
- https://doi.org/10.1080/2162402X.2015.1011527